Science Explorer Back to mapMap

Jeffrey W. Strovel

Jeffrey W. Strovel publishes mostly in Molecular Biology, Hematology and Oncology, on topics such as Protein Degradation and Inhibitors, Multiple Myeloma Research and Treatments and Biochemical and Molecular Research.

OpenAlex
World rank
#6,210,769
of 7,710,434 ranked researchers
Rank in United States
#1,489,906
of 1,627,098
Works
87
Citations
445
Citations per work
5.1
h-index
12
i10-index 14Top 65% in Molecular Biology

What does Jeffrey W. Strovel research?

Jeffrey W. Strovel's work is mostly in Biochemistry, Genetics and Molecular Biology (30%), Medicine (20%), Economics, Econometrics and Finance (5%).

Life Sciences30%Physical Sciences3%Health Sciences20%Social Sciences5%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else3742.4%
    1. Biochemistry, Genetics and Molecular Biology2630.0%
    1. Medicine1720.0%
    1. Economics, Econometrics and Finance44.7%
    1. Engineering32.9%
  1. 1Molecular Biology30% of their works
  2. 2Hematology8% of their works
  3. 3Oncology7% of their works
  4. 4Economics and Econometrics5% of their works
  5. 5Public Health, Environmental and Occupational Health5% of their works
  6. 6Aerospace Engineering3% of their works

Research topics

Which keywords describe Jeffrey W. Strovel's research?

The keywords of their largest research topics: Cancer Therapy, Proteasome Inhibitors, BET Bromodomains, PROTACs, Diagnosis Criteria, International Myeloma Working Group, Enzyme Regulation and Nucleotide Metabolism.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Cancer Therapy183 topics
  2. Proteasome Inhibitors162 topics
  3. BET Bromodomains151 topic
  4. PROTACs151 topic
  5. Diagnosis Criteria111 topic
  6. International Myeloma Working Group111 topic
  7. Enzyme Regulation81 topic
  8. Nucleotide Metabolism81 topic
  9. Fibroblast Activation Protein71 topic
  10. Financial Analysis71 topic
  11. Monetary Policy71 topic
  12. Tumor Microenvironment71 topic
  13. HDAC Inhibitors61 topic
  14. Histone Deacetylases61 topic
  15. Hypersonic Effect51 topic
  16. Proteasome51 topic
  17. Ubiquitin51 topic
  18. Ultrasonic Perception51 topic

Where does Jeffrey W. Strovel work?

Jeffrey W. Strovel's main affiliation in the publication record is Avalon Pharma (United States), United States.

How many publications and citations does Jeffrey W. Strovel have?

OpenAlex counts 87 works and 445 citations for Jeffrey W. Strovel, an h-index of 12, ranking #6,210,769 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Jeffrey W. Strovel. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.